Disease
Health

Canavan Disease

3D illustration of a purple Bloom syndrome protein structure against a soft pink background.

Summary

  • What it is: A progressive, fatal neurological disorder where the brain's white matter (myelin) degenerates, preventing the proper transmission of nerve signals.1
  • Jewish Connection: One of the most common Jewish genetic diseases; approximately 1 in 40 Ashkenazi Jews is a carrier.2
  • The Science: Caused by mutations in the ASPA gene, which leads to a deficiency of the enzyme aspartoacylase and a toxic buildup of N-acetylaspartic acid (NAA) in the brain, destroying the myelin sheath that surrounds the nerves.1,3
  • Key Symptoms: Initial signs include poor head control, hypotonia, an abnormally large head (macrocephaly), and significant developmental delays starting in early infancy.3
  • Future Hope: While current care is supportive, active clinical trials are investigating gene therapy to restore enzyme function in the brain.4

What is Canavan Disease?

Canavan disease is a rare, inherited neurological disorder characterized by the degeneration of the white matter in the brain. White matter is composed of myelinated fibers and acts as the protective insulation for nerve fibers. When myelin deteriorates, it disrupts the brain's ability to send and receive signals, leading to severe physical and cognitive impairment.1,5

Symptoms and Clinical Features

Symptoms typically appear between three and six months of age.1 The disease progresses rapidly, and infants usually miss significant developmental milestones. Symptoms and clinical features include:

  • Macrocephaly: An abnormally large head size and poor muscle tone (hypotonia), specifically poor head control, are often the first visible signs.3
  • Developmental Delays: Children typically do not learn to sit, stand, walk, or speak.5
  • Visual Impairment: Most children develop optic atrophy, which can lead to blindness3
  • Seizures and Stiffness: As the disease progresses, children may develop life-threatening seizures and physical stiffness (spasticity).1
  • Feeding Difficulties: Swallowing becomes increasingly difficult over time, often requiring the use of a feeding tube.5

How Common is Canavan Disease?

While Canavan disease occurs in all populations, its prevalence among people of Ashkenazi Jewish descent is as follows:

  • Carrier Rate: Approximately 1 in 40 individuals of Ashkenazi Jewish descent carry a mutation in the ASPA gene.2,3
  • Disease Prevalence: In the Ashkenazi population, the disease affects approximately 1 in 6,400 to 13,500 births.3

How Inheritance Works

Canavan disease is an autosomal recessive disorder.

  • Carriers: Carriers have one copy of the ASPA gene that contains a mutation, making it non-working, and one mutated gene and one working copy of the gene. Carriers are typically healthy individuals without symptoms.2
  • Reproductive planning considerations: If both parents are carriers, there is a 25% chance with each pregnancy that their child will be affected.2

Diagnosis and Screening

  • Carrier Screening: Because carriers show no symptoms, genetic testing is crucial for prospective parents to know their risk before or during pregnancy.2
  • Diagnostic Testing: For symptomatic infants, their medical team will likely start with a urine test, a brain scan, and/or a cerebrospinal fluid test, all of which check for elevated levels of NAA. DNA analysis of the ASPA gene can confirm the diagnosis.3,4

Treatment and Prognosis

Currently, there is no cure for Canavan disease, and treatment focuses on supportive care:

  • Management: Therapies focus on maintaining nutrition (feeding tubes), managing seizures with medication, and using physical therapy to improve posture.1
  • Gene Therapy Research: The Canavan community is at the forefront of genetic research. Several active clinical trials are investigating gene transfer technology to deliver a functional ASPA gene directly to brain cells.5
  • Prognosis: Most children with Canavan disease do not survive past childhood or adolescence, though some individuals live into their teens or early twenties with intensive medical support.3

References

  1. National Organization for Rare Disorders (NORD). Canavan Disease. Updated February 2024. Accessed April 23, 2026. https://rarediseases.org/rare-diseases/canavan-disease/
  2. Cleveland Clinic. Canavan Disease: Symptoms, Causes, and Carrier Rates. Published January 15, 2025. Accessed April 23, 2026. https://my.clevelandclinic.org/health/diseases/24432-canavan-disease
  3. NIH. Canavan disease. Published 2023. Accessed April 23, 2026. https://www.ncbi.nlm.nih.gov/books/NBK1234/
  4. National Institute of Neurological Disorders and Stroke (NINDS). Canavan Disease Information Page and Clinical Research. Updated March 2024. Accessed April 23, 2026. https://www.ninds.nih.gov/health-information/disorders/canavan-disease
  5. MedlinePlus. Canavan disease. National Library of Medicine. Updated April 2024. Accessed April 23, 2026. https://medlineplus.gov/genetics/condition/canavan-disease/

‍